https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-26 / Cancers (Basel) 2018 Sep;10(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-26 / Cancers (Basel) 2018 Sep;10(10)2018-09-26 00:00:002018-09-26 00:00:00The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-09-07 / Integr Cancer Ther 2018 12;17(4):1297-1303
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-09-07 / Integr Cancer Ther 2018 12;17(4):1297-13032018-09-07 00:00:002019-03-27 11:12:22Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-19 / Clin. Cancer Res. 2018 Oct;24(19):4900-4912
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-19 / Clin. Cancer Res. 2018 Oct;24(19):4900-49122018-06-19 00:00:002018-06-19 00:00:00Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-02-22 / Sci Rep 2018 Feb;8(1):3474
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-02-22 / Sci Rep 2018 Feb;8(1):34742018-02-22 00:00:002018-02-22 00:00:00Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-01-10 / Oncotarget 2018 Feb;9(11):10110-10117
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-01-10 / Oncotarget 2018 Feb;9(11):10110-101172018-01-10 00:00:002018-01-10 00:00:00A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-06-05 / J Clin Oncol 35, 2017 (suppl; abstr 3089)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-06-05 / J Clin Oncol 35, 2017 (suppl; abstr 3089)2017-06-05 12:09:062019-07-17 12:09:34Association of autologous AdHER2 dendritic cell vaccination with antitumor activity and number of circulating tumor cells.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-07 / Breast 2017 Jun;33:159-165
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-07 / Breast 2017 Jun;33:159-1652017-04-07 00:00:002017-04-07 00:00:00Reirradiation for locally recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-03-13 / Sci Rep 2017 03;7:43961
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-03-13 / Sci Rep 2017 03;7:439612017-03-13 00:00:002017-03-13 00:00:00Optimizing non-invasive radiofrequency hyperthermia treatment for improving drug delivery in 4T1 mouse breast cancer model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-01 / Adv Exp Med Biol 2017;1026:315-330
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-01 / Adv Exp Med Biol 2017;1026:315-3302017-01-01 00:00:002017-01-01 00:00:00Progress in Vaccine Therapies for Breast Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-12-13 / Clin Cancer Res 2017 Jun;23(12):2961-2971
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-12-13 / Clin Cancer Res 2017 Jun;23(12):2961-29712016-12-13 00:00:002023-03-07 13:00:25Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2 DCIS Independent of Route: Results of Randomized Selection Design Trial
